FDA greenlights marketing of first Alzheimer's blood test for some patients
FDA greenlights marketing of first Alzheimer's blood test for some patientshttps://wpnnradio.com/wp-content/themes/movedo/images/empty/thumbnail.jpg150150adminadminhttps://secure.gravatar.com/avatar/790df65a416873c3f0501d984b0b24a2f32bf2af0d1509085b901ade4bbb36e7?s=96&d=mm&r=g
Japan-based Fujirebio’s test, which helps doctors diagnose Alzheimer’s disease, is intended for patients with signs of cognitive decline. source
